Objectives: Although Pseudomonas aeruginosa from cystic fibrosis patients are well known for their antibiotic resistance, isolates that are highly susceptible to multiple drug classes have also been encountered. In this study, hypersusceptible P. aeruginosa isolates were analysed for changes in intrinsic resistance mechanisms to explain the observed phenotype.
Introduction
Pseudomonas aeruginosa is well known for its intrinsic resistance to a variety of antimicrobial agents and toxic compounds as a result of reduced outer membrane permeability. Low efficiency porins and reduced fluidity of the lipopolysaccharide (LPS) leaflet comprise this barrier and slow or exclude the entry of hydrophobic and hydrophilic molecules into the cell. 1 Intrinsic resistance is not limited to low permeability, but rather augmented by the presence of several chromosomally encoded factors including a cephalosporinase and efflux pumps. The cephalosporinase gene, ampC, is expressed at a low, basal level but can be induced to significantly higher levels in the presence of certain b-lactams or the b-lactamase inhibitor, clavulanic acid. 2, 3 Two efflux systems, MexAB -OprM and MexXY, contribute to intrinsic resistance by extruding a diverse range of compounds. mexAB -oprM is constitutively expressed in wild-type cells and its product exports fluoroquinolones, b-lactams, tetracyclines, chloramphenicol, macrolides and trimethoprim. 4, 5 mexXY is expressed at low basal levels but is inducible in response to challenges by aminoglycosides, tetracyclines and erythromycin. 6, 7 The contribution of low membrane permeability, b-lactamase and efflux pumps to intrinsic resistance in P. aeruginosa has been highlighted in laboratory-derived, hypersusceptible mutants defective in one or more intrinsic factor. Alterations in the chemical composition of the membrane 8, 9 and disruptions in metabolic pathways that serve in membrane synthesis 10 have been shown to enhance the susceptibility of P. aeruginosa to various drugs. For example, a hypersusceptible mutant 10 was created through the inactivation of the regulatory gene, glmR, which controls the expression of glmS; the product of the gene, GlmS, participates in LPS and peptidoglycan synthesis.
11 glmR mutants were shown to overexpress glmS and have more permeable membranes. 10 The participation of b-lactamase and efflux in intrinsic resistance has been illustrated in studies with knockouts of these genes. Inactivation of mexAB -oprM, mexXY and ampC alone or in combination with each other resulted in increased antibiotic susceptibility. 7,12 -14 The mechanism(s) of hypersusceptible phenotypes among clinical isolates has been largely unexplored. A couple of studies from the early 1970s and 1980s reported the isolation of hypersusceptible P. aeruginosa from clinical specimens. 15, 16 Remarkably, these strains were acquired from cystic fibrosis patients, who typically are colonized with antibiotic-resistant strains of P. aeruginosa. 17, 18 These hypersusceptible P. aeruginosa were present in the sputa among a heterogeneous population of isolates with varying susceptibilities and occurred independently of the mucoidy phenotype. 15, 16 Only a single hypersusceptible isolate from these earlier studies has been examined to identify the molecular mechanism(s) responsible for this phenotype. The up-regulation of a 32 kDa outer membrane protein and two chromosomal loci, blsA and tspA1, were reported to participate in hypersusceptibility in this isolate. 19 However, the function of the 32 kDa outer membrane protein and blsA and tspA1 gene products was never identified and the contributions of other intrinsic factors (i.e. efflux, b-lactamase and glmS overexpression) were not evaluated. Similarly, hypersusceptible P. aeruginosa isolates (defined as isolates with MICs of multiple drugs !4-fold below that for the laboratory strain PAO1) were identified during a study of cystic fibrosis patients by our laboratory. In this report, two of these hypersusceptible cystic fibrosis isolates were examined for alterations within the intrinsic resistance machinery to account for the observed phenotype. Analysis of these types of strains may offer important clues on how to overcome intrinsic resistance in P. aeruginosa.
Materials and methods
Bacterial strains and susceptibility testing P. aeruginosa strains PA30 and PA431 were isolated from sputum samples of two different cystic fibrosis patients. Wild-type P. aeruginosa strain PAO1 was used as a comparator. Isolates were initially screened for susceptibility by the Kirby-Bauer disc test 20 using antibiotic discs from Becton Dickinson (Sparks, MD, USA). Antimicrobial susceptibility was also determined by the agar dilution method according to the CLSI. 20 
Macrorestriction analysis
Strain relatedness was determined using PFGE according to the Centers for Disease Control and Prevention PulseNet protocol.
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DNA restriction patterns were analysed using BioNumerics software (v. 4.6; Applied Maths, Kortrijk, Belgium) with unweighted pair group arithmetic averages (UPGMA) and Dice coefficients.
Primer efficiency analysis
Since sequence variations in primer sites may influence the rate of amplification during PCRs, the efficiency of the primers used for the expression studies of efflux and porin genes was tested by realtime PCR. DNA was isolated from PAO1 and the clinical isolates using the Qiagen DNeasy Blood & Tissue Kit (Qiagen Inc., Valencia, CA, USA). Real-time PCR was performed using 250 ng of template and with the same conditions as RT-PCR, excluding the reverse transcription step. Primers were considered efficient if a 2 threshold cycle (C T ) difference was observed in comparison with PAO1.
RNA isolation and real-time RT-PCR
RNA was isolated from logarithmic cultures of P. aeruginosa and expression of the various genes was measured by real-time RT-PCR using previously described techniques. 22 Primers used for the detection of the glmS, mexA, mexC, mexE, mexX, oprM, oprD, oprF and ampC transcripts are listed in Table 1 . Expression of the endogenous control gene, rpsL, was used to normalize the data.
Induction of ampC expression
PAO1 and PA30 cultures were grown to mid-log phase (OD 600 0.5) and then incubated in the presence or absence of 2Â or 0.25Â the imipenem MIC for an additional 20 min. A short induction period of 20 min was used to minimize the effects of cellular killing at 2Â the MIC on ampC induction. Total RNA and cell-free lysates were prepared from untreated and imipenem-treated (2Â or 0.25Â the MIC) cultures. The level of ampC induction was determined by measuring ampC transcript levels (real-time RT-PCR) and b-lactamase activity (spectrophotometric assay) according to previously described methods. 22 
Outer membrane protein analysis
Cell membranes were collected and outer membrane proteins were analysed by SDS-PAGE with 10% (w/v) acrylamide and 0.3% N,N 0 -methylenebisacrylamide as previously described. 23 
Results

Genetic relatedness and strain susceptibility
Strains PA30 and PA431 were genetically unrelated to each other as determined by PFGE analysis (data not shown), suggesting that the supersusceptible phenotypes were not inherent to one particular type of strain. PA30 and PA431 were highly susceptible to several of the antibiotics tested, especially the b-lactams. In comparison with the wild-type strain PAO1, PA30 and PA431 were 4-fold more susceptible to cefepime and were at least 8-fold more susceptible to piperacillin+ tazobactam, aztreonam, imipenem and meropenem (Table 2 ). In addition, PA30 was 4-fold more susceptible to ceftazidime. PA30 and PA431 were 16-fold more susceptible to the antimetabolite combination, trimethoprim/sulfamethoxazole, and PA30 was 4-to 8-fold more susceptible to the fluoroquinolones, ciprofloxacin and levofloxacin, respectively (Table 2 ). Conversely, PA431 was 4-fold less susceptible than PAO1 to both ciprofloxacin and levofloxacin.
Expression of glmS
To determine if glmS overexpression contributed to the supersusceptible pattern observed in PA30 and PA431, the level of glmS expression was examined in these strains compared with PAO1. glmS expression was similar in PA30 and PAO1 but was downregulated $9.1-fold in PA431 (Table 3) . These results suggest that the GlmS metabolic pathway is not responsible for the hypersusceptible phenotype in PA30 and PA431.
Efflux pump expression
Hypersusceptibility in these strains could be attributed to alterations in efflux pump production, such as a down-regulation of mexAB -oprM expression. Therefore, the expression of four well-characterized efflux systems (mexAB -oprM, mexCD -oprJ, mexEF -oprN and mexXY) known to affect antibiotic susceptibilities was examined in PA30 and PA431. Expression of the first gene in each operon was measured by real-time RT-PCR and compared with that in PAO1. Since differential expression may exist between mexA and oprM as a result of an internal promoter contributing to oprM expression, 24 the levels of oprM transcript were also examined. In comparison with PAO1, PA30 expressed mexA and oprM at $3-fold lower levels (Table 3) , indicating pump down-regulation. mexA was expressed at 2-fold higher levels in PA431, but, in contrast to mexA, oprM expression was decreased by $7-fold in PA431 compared with PAO1. Surprisingly, mexC and mexE, normally expressed at very low basal levels in wild-type cells, showed 340-to 375-fold higher expression, respectively, in PA30 than in PAO1, but expression of these pumps only increased $3-to 4-fold in strain PA431. PA431 expressed 50-fold higher levels of mexX transcript compared with PAO1 (Table 3 ) but its expression was 2-fold lower in PA30.
Porin expression and production
Since porins facilitate the entry of drugs into the cell, a higher production of these channels would allow for increased penetration and susceptibility. Therefore, porin production was evaluated in strains PA30 and PA431 by outer membrane protein analysis and mRNA expression. Surprisingly, the level of OprD in the outer membrane of strains PA30 and PA431 (Figure 1 ) was dramatically reduced compared with PAO1, corresponding to 13-to 20-fold lower transcriptional expression of oprD (Table 3 ). The loss of OprD conflicted with carbapenem susceptibility as both strains were hypersusceptible to imipenem and meropenem (Table 2) . Conversely, SDS-PAGE demonstrated the overproduction of the OprF porin in PA30 and PA431 (Figure 1) . Interestingly, expression of oprF in PA30 and PA431 did not correlate with higher amounts of protein as transcript levels were similar to those of PAO1 (Table 3) .
b-Lactamase induction in strain PA30
The inducible cephalosporinase, AmpC, in P. aeruginosa contributes to the intrinsic resistance of this organism to certain b-lactams such as the cephamycins (e.g. cefoxitin). Cephamycins induce higher levels of ampC expression in wildtype P. aeruginosa and are labile to AmpC hydrolysis. 25 During initial susceptibility screening of PA30 and PA431 by disc diffusion, PA431 was resistant to cefoxitin (6 mm zone) as expected, but PA30 yielded a susceptible zone (32 mm) around the cefoxitin disc, suggesting either a defect in the induction pathway or mutations within the ampC structural gene that altered its spectrum of activity. To determine if the ampC induction pathway was impaired, the levels of ampC transcript and b-lactamase activity were measured in PA30 grown in the presence or absence of inducing agent (imipenem) and results were compared with PAO1. When challenged with imipenem at 0.25Â the MIC (0.25 mg/L), PAO1 expressed ampC at 2358-fold higher levels, correlating with $261-fold higher b-lactamase activity compared with the untreated culture (Table 4) . Imipenem-treated cultures of PA30 at 0.25Â the MIC (0.03 mg/L) only expressed ampC at a 7-fold higher level and had $2.8-fold more b-lactamase activity than untreated cultures. Thus, the induction potential of ampC in PA30 was 337-and 93-fold less than in PAO1 with regard to transcript and b-lactamase activity levels, respectively. When a concentration of 2Â the MIC (0.25 mg/L) was used for ampC induction in PA30 (the same concentration used to induce ampC in PAO1 at 0.25Â the MIC), ampC was expressed at 62-fold higher levels, corresponding to 19-fold more b-lactamase activity than in untreated cultures (Table 4) . Even though the same concentration of inducing agent was used for PA30 as for PAO1, the induction potential of ampC in PA30 was still 38-and 14-fold lower for ampC transcript and b-lactamase activity levels, respectively, than in PAO1.
Discussion
Two genetically unrelated P. aeruginosa cystic fibrosis isolates showed unusual susceptibility phenotypes to multiple drug classes. PA30 was hypersusceptible to antibiotics from three different drug classes, b-lactams, fluoroquinolones and antimetabolites. PA431 was hypersusceptible to several members of the b-lactam class and to antimetabolites. Although hypersusceptibility has previously been linked to overexpression of glmS in response to inactivation of glmR, 10 strains PA30 and PA431 did not overexpress glmS, indicating an alternative mechanism(s) involved in producing this phenotype.
The common traits shared between PA30 and PA431 involve the same changes in porin expression and production. Both strains significantly overproduced OprF compared with the wildtype strain PAO1. A definitive role for OprF in antibiotic uptake has yet to be proven; however, previous studies have offered support for this function. A multidrug-resistant strain of P. aeruginosa that lacked OprF was reported by Piddock et al., 26 and reversion of this strain to a susceptible phenotype correlated with restored OprF production. In another study, OprF-deficient strains created through insertional mutagenesis of the gene had modest increases in MICs. 27 Alternatively, high-level production of this porin may yield an increased percentage of open channels and, consequently, increased susceptibility of this organism to drugs that utilize this route. Interestingly, the increased amount of OprF protein was not associated with enhanced transcription of oprF. This discrepancy has been reported previously by Malhotra et al. 28 in an alginate-producing mutant and suggests that regulation of the porin may involve post-transcriptional mechanisms.
Strains PA30 and PA431 also had altered levels of the porin OprD. The amount of OprD in the outer membrane was diminished in both strains, corresponding to a significant decrease in transcriptional expression of oprD. OprD serves as a channel for carbapenem molecules (e.g. imipenem and meropenem) to enter into the cell, 29 and loss of this porin typically results in imipenem resistance and decreased meropenem susceptibility. 30 Surprisingly, imipenem and meropenem MICs were at least 8-fold lower in PA30 and PA431 compared with PAO1, despite the reduced amount of OprD. Hypersusceptibility to imipenem has also been observed in an OprD-deficient strain overexpressing the mexCD -oprJ efflux pump. 22 Increased carbapenem susceptibility despite the loss of OprD represents a perplexing situation and may suggest that carbapenems can enter through an alternative route.
Variations in efflux pump expression were detected in the hypersusceptible strains. In PA30, expression of the main pump involved in intrinsic resistance, mexAB -oprM, was decreased, which may partially explain hypersusceptibility to agents exported by this pump, such as ceftazidime, fluoroquinolones and trimethoprim/sulfamethoxazole. 4, 5 Interestingly, PA30 overexpressed two additional efflux systems, mexCD -oprJ and mexEF -oprN, known to cause antimicrobial resistance. 31 Li et al. 32 previously showed an inverse correlation between expression of mexAB -oprM and expression of mexCD -oprJ and mexEF -oprN. The reduced levels of mexAB -oprM in PA30 may have triggered increased expression of the other two pumps to compensate for its loss.
PA431 exhibited a dichotomy between expression of the first gene and the last gene in the mexAB -oprM operon. While mexA was expressed 2-fold more than in PAO1, oprM transcript levels were $7-fold lower. Expression of oprM is controlled not only by the promoter driving mexA -mexB but also by a second promoter located within the mexB structural gene. 24 Alterations within this second promoter may have led to decreased oprM mRNA. Alternatively, mutations within mexA -mexB may have resulted in premature termination of oprM transcription. A reduction in the outer membrane component of the tripartite efflux system most probably decreased the total amount of MexAB -OprM pumps present in the membrane, possibly leading to hypersusceptibility in PA431. PA431 overexpressed the mexXY efflux pump, which may be responsible for the elevated MICs of the fluoroquinolones, substrates of this pump. In addition to OprM, MexXY has been suggested to function with other outer membrane proteins to form a complete tripartite pump. 33 Hence, the down-regulation of oprM expression in PA431 may not necessarily reduce the function of MexXY in fluoroquinolone export.
Fluoroquinolones are also substrates for mexCD -oprJ and mexEF -oprN, and overexpression of these pumps alone has led to decreased susceptibility or resistance to this drug class. 31 Yet, fluoroquinolone MICs for PA30 were 4 -8-fold less than for PAO1 despite overexpression of both pumps. Cefepime is a substrate for mexCD -oprJ and mexXY, 34, 35 and their overexpression should lead to elevated cefepime MICs. In contradiction, PA30 and PA431 were hypersusceptible to cefepime. The reason why overexpression of these pumps did not decrease susceptibility to their reported substrates remains unknown.
Finally, PA30 was hypersusceptible to cefoxitin, which correlated with a defect in the ampC induction pathway. Compared with PAO1 induced at 0.25Â the MIC, PA30 had significantly lower b-lactamase activity corresponding to lower levels of ampC transcript even when higher imipenem concentrations (2Â the MIC) were used to induce ampC. Several factors are required for ampC induction in P. aeruginosa, including the AmpR regulatory protein, AmpG permease and amidase homologues (AmpD, AmpDH2 and AmpDH3). 36 The induction pathway is intimately linked to cell wall recycling and requires the presence of an inducing cofactor, anhydromuropeptides, 37 which are processed by the amidase homologues. 38 Mutations and/or expression changes in any of these factors could prevent AmpR activation and suppress ampC induction. For example, inactivation of ampG prevents the uptake of the anhydromuropeptides (i.e. AmpR-inducing cofactor) rendering the cells non-inducible and maintaining ampC expression at a low basal state. 39 Alternatively, overexpression of an amidase gene could result in more rapid anhydromuropeptide turnover, preventing an increase in the cytoplasmic pools of the inducing cofactor. Further investigation into the ampC induction pathway is necessary to determine the role these factors may play in the lower induction potential for PA30.
Hypersusceptible isolates PA30 and PA431 represent perplexing organisms that have undergone complex adaptive processes within the cystic fibrosis lung including multiple changes in efflux pump, porin and b-lactamase expression. The phenotype of these strains did not always correlate with the presence/absence of a particular resistance mechanism. Cystic fibrosis isolates of P. aeruginosa have received significant attention over the years regarding their mucoid polysaccharide production and antibiotic resistance mechanisms that help enable these strains to survive therapy. The hypersusceptible strains in this study and those described in earlier reports 15, 16 may offer a unique insight into the vulnerability of a difficult-to-treat pathogen.
